HIGHBRIDGE CAPITAL MANAGEMENT LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 68 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q4 2022$15,244
-99.9%
1,482,836
-28.4%
0.42%
+43.8%
Q3 2022$20,814,000
+46.7%
2,071,051
+46.7%
0.29%
-9.6%
Q2 2022$14,192,000
+21.1%
1,412,107
+19.0%
0.32%
+18.3%
Q1 2022$11,719,0001,186,1490.27%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders